1. Epidemiology, etiology, and diagnosis of health care acquired pneumonia including ventilator-associated pneumonia in Nepal
- Author
-
Louise Thwaites, Nhukesh Maharjan, Sarita Pyatha, Buddha Basnyat, Sabina Dongol, K C Rajkumar, Gyan Kayastha, Abhilasha Karkey, Stephen Baker, Baker, Stephen [0000-0003-1308-5755], and Apollo - University of Cambridge Repository
- Subjects
Pulmonology ,Nosocomial Infections ,Epidemiology ,law.invention ,Geographical Locations ,Cohort Studies ,Medical Conditions ,Interquartile range ,law ,Medicine and Health Sciences ,Medicine ,Prospective Studies ,Multidisciplinary ,Incidence (epidemiology) ,Ventilator-associated pneumonia ,Pneumonia, Ventilator-Associated ,Middle Aged ,Intensive care unit ,Hospitals ,Anti-Bacterial Agents ,Intensive Care Units ,Exact test ,Infectious Diseases ,Research Article ,Cohort study ,Adult ,medicine.medical_specialty ,Asia ,Science ,Surgical and Invasive Medical Procedures ,Respiratory Disorders ,Nepal ,Internal medicine ,Humans ,Aged ,business.industry ,Pneumonia ,medicine.disease ,respiratory tract diseases ,Health Care ,Health Care Facilities ,Respiratory Infections ,People and Places ,Intubation ,business - Abstract
Epidemiologic data regarding health care acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) from Nepal are negligible. We conducted a prospective observational cohort study in the intensive care unit (ICU) of a major tertiary hospital in Nepal between April 2016 and March 2018, to calculate the incidence of VAP, and to describe clinical variables, microbiological etiology, and outcomes. Four hundred and thirty-eight patients were enrolled in the study. Demographic data, medical history, antimicrobial administration record, chest X-ray, biochemical, microbiological and haematological results, acute physiology and chronic health evaluation II score and the sequential organ failure assessment scores were recorded. Categorical variables were expressed as count and percentage and analyzed using the Fisher’s exact test. Continuous variables were expressed as median and interquartile range and analyzed using Kruskal-Wallis rank sum test and the pairwise Wilcoxon rank—sum test. 46.8% (205/438) of the patients required intubation. Pneumonia was common in both intubated (94.14%; 193/205) and non-intubated (52.36%; 122/233) patients. Pneumonia developed among intubated patients in the ICU had longer days of stay in the ICU (median of 10, IQR 5–15, P< 0.001) when compared to non-intubated patients with pneumonia (median of 4, IQR 3–6, P< 0.001). The incidence rate of VAP was 20% (41/205) and incidence density was 16.45 cases per 1,000ventilator days. Mortality was significantly higher in patients with pneumonia requiring intubation (44.6%, 86/193) than patients with pneumonia not requiring intubation (10.7%, 13/122, pKlebsiella and Acinetobacter species were the dominant organisms from both VAP and non-VAP categories. Multi-drug resistance was highly prevalent in bacterial isolates associated with VAP (90%; 99/110) and non-VAP categories (81.5%; 106/130). HAP including VAP remains to be the most prevalent hospital-acquired infections (HAIs) at Patan hospital. A local study of etiological agents and outcomes of HAP and VAP are required for setting more appropriate guidelines for management of such diseases.
- Published
- 2021
- Full Text
- View/download PDF